|Articles|October 12, 2012
Trading Away the Medicines of Tomorrow
Author(s)Mike Hennessy
Advertisement
One of the major issues being negotiated right now the amount of protection for the intellectual property of pharmaceutical and biotech companies. And failure to protect the intellectual property rights will actually hurt patients more than the companies.
Click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Medical Economics
1
FDA clears Wellvii's finger-based blood pressure monitor for home use
2
10 numbers that show prior authorization is still broken
3
Most patients view test results before hearing from a physician
4
‘Someone needs to own the retention strategy’ — keeping physicians on the job, or not
5